Membership Application Form

1
Membership Type
2
Personal Information
3
Last Page

1. Membership Type

Full Member - Full Membership is open to Australian and New Zealand health professionals and researchers with an interest in brain tumour clinical trials.

Associate member (Overseas) - Open to healthcare professionals and researchers outside Australia or New Zealand with an interest in brain tumour clinical trials.

Associate member (Consumer) - Open to consumer advocates and community members (including patients and carers) interested in brain tumour clinical trials.

Associate member (Industry) - Open to industry representatives with an interest in brain tumour clinical trials.

Maximum file size: 5 MB
PROPOSED By (admin) *
Seconded By (admin) *

If you are unable to identify a proposer and/or seconder please contact COGNO who may be able to assist you.

Do you give permission for your name to appear on the list of proposers and seconders?

2. Personal Information

3. Professional Details

Are the majority of patients you deal with children? *
Different postal address?

COGNO Membership

Membership of the group is free and does not need to be renewed annually. Interested parties should complete the online membership application and select a proposer and seconder from the drop down list of current COGNO members. Interested parties who don’t know two current members should contact COGNO to determine the closest current members in your area. Received applications for membership are then ratified by the COGNO Management Committee.


Members will be advised once their application has been ratified. On an ongoing basis, members will receive membership newsletters by email detailing the group’s activities, including opportunities to be involved in COGNO trials and trial development, and information on the annual scientific meeting.


Should you require more information, please contact cogno@ctc.usyd.edu.au
We look forward to receiving your completed membership application.

Membership benefits include:

Your donations to our Brain Tumour Research make a real difference